Major study launches to uncover hidden health risks of early menopause
NCT ID NCT06067529
First seen Jun 01, 2026 · Last updated Jun 15, 2026 · Updated 3 times
Summary
This study is for women under 40 who have premature ovarian insufficiency (POI), a condition where the ovaries stop working early. Researchers will follow 1080 participants over time to understand what causes POI and how it affects bone health, hormones, mood, and overall well-being. The goal is to gather information to improve diagnosis, treatment, and long-term care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREMATURE OVARIAN INSUFFICIENCY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Women's Hospital School of Medicine Zhejiang University
RECRUITINGHangzhou, Zhejiang, 310000, China
-
Women's Hospital School of Medicine Zhejiang University
NOT_YET_RECRUITINGHangzhou, Zhejiang, 310000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.